Antiplatelet treatment in primary and secondary stroke prevention in women

Antiplatelet treatment in primary and secondary stroke prevention in women

Show other versions (1)

Bibliographic Details
Main Authors:	Caso, V, Santalucia, P, Acciarresi, M, Pezzella, F, Paciaroni, M
Format:	Journal article
Published:	2012

Similar Items

Antiplatelet treatment in primary and secondary stroke prevention in women.
by: Caso, V, et al.
Published: (2012)

Call for Research on Women on behalf of women stroke association
by: Santalucia, P, et al.
Published: (2014)

Antiplatelets in secondary stroke prevention
by: Olga eShulga, et al.
Published: (2011-07-01)

Women Stroke Association statement on stroke
by: Pezzella, F, et al.
Published: (2014)

Antiplatelet therapy as an element of primary and secondary prevention of ischemic stroke
by: E. Y. Solovyova, et al.
Published: (2016-12-01)

Call for research on women on behalf of WSA
by: Santalucia, P, et al.
Published: (2014)

Antiplatelet therapy in secondary prevention of ischemic stroke
by: V. A. Parfyonov, et al.
Published: (2015-12-01)

ANTIPLATELET AGENTS IN THE TREATMENT AND SECONDARY PREVENTION OF ISCHEMIC STROKE (REVIEW OF LITERATURE)
by: E. Y. Kitaeva, et al.
Published: (2017-04-01)

Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom
by: Xuejun Liu, et al.
Published: (2023-10-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
by: Ellen O'Brien, et al.
Published: (2023-02-01)

Sex differences in clinical presentation, severity and outcome of stroke: Results from a hospital-based registry
by: Santalucia, P, et al.
Published: (2012)

Sex differences in clinical presentation, severity and outcome of stroke: results from a hospital-based registry.
by: Santalucia, P, et al.
Published: (2013)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
by: Srivastava Padma
Published: (2010-01-01)

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation
by: Michela Giustozzi, et al.
Published: (2020-05-01)

Secondary prevention with antiplatelet medications in patients with antiphospholipid antibody-related stroke
by: Wookjin Yang, et al.
Published: (2025-03-01)

Antiplatelet agents in stroke prevention.
by: Peto, R
Published: (1988)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
by: Hennekens, C, et al.
Published: (1989)

TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
by: Muhammad Tariq, et al.
Published: (2018-12-01)

Editorial: Antiplatelet Agents in Stroke Prevention
by: Gergely Feher, et al.
Published: (2021-09-01)

Precision antiplatelet therapy for the prevention of ischaemic stroke
by: David Wang

Research progress of new antiplatelet drugs in the prevention and treatment for ischemic stroke
by: Pan LI, et al.
Published: (2013-04-01)

Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines
by: Wengui Yu, et al.

Antiplatelet agents for the treatment and prevention of atherothrombosis.
by: Patrono, C, et al.
Published: (2011)

Primary and Secondary Prevention of Strokes
by: N. A. Fomina-Chertousova, et al.
Published: (2012-09-01)

Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?
by: Clotilde Balucani, et al.
Published: (2010-01-01)

Differences in primary and secondary stroke prevention strategies for Chinese men and women
by: Zenghua Xie, et al.
Published: (2023-06-01)

ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF STROKE
by: P. S. Laguta
Published: (2017-05-01)

PREVENTION OF ISCHEMIC STROKE Antiplatelet Agents, Carotid Endarterectomy and Angioplasty and Stenting
by: Harold P. Adams
Published: (2008-12-01)

Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack
by: A. V. Fonyakin, et al.
Published: (2021-10-01)

Abstract 136: Antiplatelet Regimens for Secondary Prevention in Minor Ischemic Stroke or TIA: A Network Meta‐Analysis
by: Hesham Kelani
Published: (2023-11-01)

Antiplatelet Therapy in the Secondary Prevention of Non-cardioembolic Ischemic Stroke and Transient Ischemic Attack: A Mini-Review
by: Martin Vališ, et al.
Published: (2021-02-01)

Gene-Drug Interaction in Stroke
by: Serena Amici, et al.
Published: (2011-01-01)

Aspirin for Primary Stroke Prevention; Evidence for a Differential Effect in Men and Women
by: Zuzana Gdovinova, et al.
Published: (2022-06-01)

Antiplatelet therapy strategies for ischemic stroke
by: M. Yu. Maksimova, et al.
Published: (2017-07-01)

A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility.
by: Nikola Sprigg, et al.
Published: (2008-08-01)

Dabigatran experience in primary and secondary prevention of cardioembolic stroke
by: Maksim Alekseyevich Domashenko, et al.
Published: (2013-11-01)

Antiplatelet combinations for prevention of atherothrombotic events
by: Anselmino M, et al.
Published: (2011-01-01)

Dual Antiplatelet Therapy for the Acute Management and Long-term Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack, An Updated Review
by: Bernard P. L. Chan, et al.
Published: (2024-01-01)

Advances in Our Understanding of “Resistance” to Antiplatelet Agents for Prevention of Ischemic Stroke
by: Philip B. Gorelick, et al.
Published: (2013-01-01)

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis
by: Patrono, C, et al.
Published: (2017)